Position in SABS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$780
+$14 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 86 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GS Investments, Inc. holds $1,052 across 2 Biotechnology names. SABS ranks #1 (74.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SABS |
SAB Biotherapeutics, Inc.
This page
|
200 | $780 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
5 | $272 |
All Filings in SABS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $780 | 200 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $766 | 200 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $748 | 200 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $402 | 200 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $351 | 200 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $272 | 200 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $758 | 200 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $540 | 200 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $620 | 200 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $908 | 200 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,376 | 2,000 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,260 | 2,000 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,660 | 2,000 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $880 | 2,000 | Shares | Sole | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||